Broadening applications of anatomical pathology in uncovering and managing different kinds of medical conditions is a major factor expected to accelerate the growth of this market in the near future. The primary role of anatomic pathological procedures is to study the effect of abnormalities on the structure of body organs for tumor prognosis and management. The rising incidence of life-threatening medical conditions such as cancer, renal disorders, liver diseases, infections, and autoimmune disorders are anticipated to raise the demand for these products. According to estimates of the American Cancer Society, around 1,688,780 new cancer cases diagnosed and noted 600,920 cancer deaths in 2017 in the U.S. High prevalence pronounces the demand for adoption of anatomic pathology in order to improve patient diagnostic imaging techniques and to reduce further complications by timely diagnosis.
In most of the inpatient settings, anatomy pathological methods is considered as a proven and efficient method for examination and in-depth visual analysis of tissues.. Moreover, incorporation of technological advancement in the imaging methods has resulted in the development of sophisticated anatomic pathology methods. For instance, the advent of barcode technology and tailored software applications in anatomic pathology workflow has resulted in the improved and cost-saving examination of surgical specimens. Additionally, pathologists are also adding the value to their testing services by implementing advanced health information technology to meet the patient’s expectation and optimize the workflow.
Moreover, a burgeoning geriatric population, increase in healthcare expenditure and rising employment of biomarkers during disease diagnosis are other factors fostering the anatomic pathology market progression. Developed nations typically mark considerable market share owing to a number of ongoing R&D programs for disease diagnosis. In addition to this, emerging nations are benefited by numerous governmental initiatives and growing awareness about novel cutting-edge technologies. For instance, Anatomic Pathology Reporting to Public Health (ARPH) and Anatomic Pathology Structured Report (APSR) reports covers the management standards in India that provide a template for transmitting reports to public health organizations..
Moreover, key players are continuously involved in R&D activities to enhance their anatomical pathology offerings and are also undergoing multiple strategic developments. For instance, in January 2016, the CliniSys subsidiary MIPS acquired Fresco Consult to enhance its product portfolio of clinical laboratory by integrating LIS DaVinci laboratory information system to its offering. Such initiatives lead to incease in the usage rate of anatomy pathological systems for clinical applications and support a wide range of diagnosis applications, oncology being a major one.
Companies operating in the global anatomic pathology market include Thermo Fisher Scientific, Inc., Syntec Scientific, Cardinal Health, Inc., CliniSys Group, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Sakura Finetek USA, Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Inc., BioGenex, and Bio SB. Aforementioned market participants are engaged in the development of anatomy pathological products and services coupled with the introduction of novel instruments for successful disease diagnosis.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."